Statin Intolerance Clinical Guide 2018-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Statin Intolerance Clinical Guide 2018

Published:2020-04-01 Issue:4 Volume:27 Page:375-396
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Kajinami Kouji¹,Tsukamoto Kazuhisa²,Koba Shinji³,Inoue Ikuo⁴,Yamakawa Masashi⁵,Suzuki Shigeaki⁶,Hamano Tadanori⁷,Saito Hidetsugu⁸,Saito Yoshiro⁹,Masuda Satohiro¹⁰,Nakayama Takeo¹¹,Okamura Tomonori¹²,Yamashita Shizuya¹³¹⁴,Kagawa Tatehiro¹⁵,Kaneyama Junji¹⁶,Kuriyama Akira¹⁷,Tanaka Rumi¹⁰,Hirata Aya¹²,

Affiliation:

1. Department of Cardiology, Kanazawa Medical University

2. Department of Internal Medicine, Teikyo University School of Medicine

3. Division of Cardiology, Department of Medicine, Showa University School of Medicine

4. Department of Endocrinology and Diabetes, Saitama Medical University

5. Department of Endocrinology and Diabetes, Yokohama City University Medical Center

6. Department of Neurology, Keio University School of Medicine

7. Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui

8. Faculty of Pharmacy, Keio University

9. Division of Medicinal Safety Science, National Institute of Health Sciences

10. Department of Pharmacy, Kyushu University Hospital

11. Graduate School of Medicine and Public Health, Kyoto University

12. Department of Preventive Medicine and Public Health, Keio University School of Medicine

13. Department of Cardiovascular Medicine, Rinku General Medical Center

14. The Institute of Scientific and Industrial Research, Osaka University

15. Division of Hepatology and Gastroenterology, Department of Internal Medicine, Tokai University School of Medicine

16. Department of Cardiovascular Medicine, Tokyo Medical University

17. Emergency and Critical Care Center, Kurashiki Central Hospital

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/27/4/27_50948/_pdf

Reference93 articles.

1. 1) Endo A. The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res, 1992; 33: 1569-1582

2. 3) Fitchett DH, Hegele RA, Verma S. Cardiology patient page. Statin intolerance. Circulation, 2015; 31: 131

3. 5) Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM. IMPROVE-IT Investigators. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med, 2015; 372: 2387-2397

4. 6) Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR: FOURIER Steering Committee and Investigators. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med, 2017; 376: 1713-1722

5. 7) Guyton JR, Bays HE, Grundy SM, Jacobson TA. The National Lipid Association Statin Intolerance Panel. An assessment by the Statin Intolerance Panel: 2014 update. J Clin Lipidol, 2014 May-Jun; 8 (3 Suppl): S72-81

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin, Ezetimibe, or Fibrate Initiation and Subsequent Use for the Primary and Secondary Prevention of Cardiovascular Diseases among Japanese Patients Aged ≥55 Years: A Nationwide Cohort Study;Biological and Pharmaceutical Bulletin;2023-11-01

2. Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022;Journal of Atherosclerosis and Thrombosis;2023-05-01

3. Safety profile of the concomitant use of atorvastatin and cyclosporine in renal transplant recipients;PHARMAZIE;2023

4. High hepatic and plasma exposures of atorvastatin in subjects harboring impaired cytochrome P450 3A4∗16 modeled after virtual administrations and possibly associated with statin intolerance found in the Japanese adverse drug event report database;Drug Metabolism and Pharmacokinetics;2023-04

5. The lipid-lowering effects of fenugreek gum, hawthorn pectin, and burdock inulin;Frontiers in Nutrition;2023-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3